Heart attack

Cardiac rejuvenation therapy: A therapeutic mix encompassing  Victoza and Atorvastatin (VA) suppresses tumor suppressor INK4a/p16 expression, promotes cardiac repair, delays cardiac ageing and senescence, and extends life span via up regulation of its target gene, 13/November/2017, 11.35 pm
Cardiac rejuvenation therapy: A therapeutic mix encompassing  Victoza and Atorvastatin (VA) suppresses tumor suppressor INK4a/p16 expression, promotes cardiac repair, delays cardiac ageing and senescence, and extends life span via up regulation of its target gene, 13/November/2017, 11.35 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Cardiac rejuvenation therapy: A therapeutic mix encompassing Victoza (also known as Liraglutide) and Atorvastatin (VA)  suppresses tumor suppressor INK4a/p16 expression,…

read more

Molecular therapy for Cardiomyopathy: A pharmacological mixture encompassing Rivaroxaban (trade name: Xarelto) and Asprin decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 10/November/2017,  12.07 pm
Molecular therapy for Cardiomyopathy: A pharmacological mixture encompassing Rivaroxaban (trade name: Xarelto) and Asprin decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 10/November/2017,  12.07 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart function through microRNA-mediated Sox6 repression.” This…

read more

Molecular therapy for attenuating pathogenesis of Myocardial infarction: Rivoglitazone, an anti-diabetic medication, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 10/November/2017, 9.01 am
Molecular therapy for attenuating pathogenesis of Myocardial infarction: Rivoglitazone, an anti-diabetic medication, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 10/November/2017, 9.01 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A recent study from Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; and Center for Systems Biology, Massachusetts General Hospital…

read more

Molecular therapy for heart regeneration and repair: A therapeutic mix encompassing Efonidipine and Verapamil, anti-hypertensive drugs, increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 8/November/2017, 11.43 pm
Molecular therapy for heart regeneration and repair: A therapeutic mix encompassing Efonidipine and Verapamil, anti-hypertensive drugs, increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 8/November/2017, 11.43 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A recent study from Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708,…

read more

Molecular therapy for heart regeneration and repair: A therapeutic mix encompassing Atorvastatin and Probucol increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 7/November/2017, 11.07 pm
Molecular therapy for heart regeneration and repair: A therapeutic mix encompassing Atorvastatin and Probucol increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 7/November/2017, 11.07 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A recent study from Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708,…

read more

Molecular therapy for heart regeneration and repair: A therapeutic mix encompassing Atorvastatin and Amlodipine increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 7/November/2017, 12.03 am
Molecular therapy for heart regeneration and repair: A therapeutic mix encompassing Atorvastatin and Amlodipine increases Agrin expression, activates Yap and ERK-mediated signaling,  replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 7/November/2017, 12.03 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A recent study from Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708,…

read more
Start Typing